Sign In
Buy CDXS
$1.40
-0.0800 (-5.41%)
At Close: Jul 31, 2026
Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board
04:05pm, Thursday, 06'th Feb 2025
REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis Appoints Christos Richards to Board of Directors
04:05pm, Thursday, 16'th Jan 2025
REDWOOD CITY, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis Announces New Employment Inducement Grants
04:05pm, Friday, 10'th Jan 2025
REDWOOD CITY, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis Announces New Employment Inducement Grants
04:05pm, Friday, 06'th Dec 2024
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
04:05pm, Tuesday, 19'th Nov 2024
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
04:05pm, Thursday, 14'th Nov 2024
—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company's double-stranded RNA ligases comp
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
04:05pm, Tuesday, 12'th Nov 2024
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
04:05pm, Monday, 11'th Nov 2024
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-
Codexis Announces New Employment Inducement Grants
04:05pm, Friday, 08'th Nov 2024
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis to Participate in Upcoming Healthcare Conferences
04:05pm, Monday, 04'th Nov 2024
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
10:48pm, Thursday, 31'st Oct 2024
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
06:31pm, Thursday, 31'st Oct 2024
Codexis (CDXS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.26 per share a year ago.
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
04:05pm, Thursday, 24'th Oct 2024
Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Platform Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Pla
Codexis Announces New Employment Inducement Grants
07:05am, Monday, 14'th Oct 2024
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis to Report Third Quarter 2024 Financial Results on October 31
04:05pm, Thursday, 10'th Oct 2024
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
